Published in Cancer Res on December 05, 2011
Adapted Physical Activity (APA) in a Breast Cancer Population. | NCT03528473
Tumor endothelial inflammation predicts clinical outcome in diverse human cancers. PLoS One (2012) 0.94
Lymphatic endothelial cells support tumor growth in breast cancer. Sci Rep (2014) 0.83
The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting. Lab Invest (2014) 0.82
Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis. J Transl Med (2012) 0.82
Quantitative phosphoproteomics analysis reveals broad regulatory role of heparan sulfate on endothelial signaling. Mol Cell Proteomics (2013) 0.81
Dll4-notch signalling blockade synergizes combined ultrasound-stimulated microbubble and radiation therapy in human colon cancer xenografts. PLoS One (2014) 0.81
Dying endothelial cells stimulate proliferation of malignant glioma cells via a caspase 3-mediated pathway. Oncol Lett (2013) 0.80
Cycling hypoxia induces a specific amplified inflammatory phenotype in endothelial cells and enhances tumor-promoting inflammation in vivo. Neoplasia (2015) 0.79
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment. Clin Exp Metastasis (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Inflammation in atherosclerosis. Nature (2002) 28.92
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science (2005) 23.44
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell (2009) 16.06
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 13.79
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell (2009) 13.09
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest (1973) 10.18
Isolation of a tumor factor responsible for angiogenesis. J Exp Med (1971) 7.12
Angiogenesis. Annu Rev Med (2006) 6.94
Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol (2009) 6.11
Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res (2007) 5.60
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med (2011) 5.54
Evolving functions of endothelial cells in inflammation. Nat Rev Immunol (2007) 4.94
Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle (2006) 4.67
NF-κB, inflammation, and metabolic disease. Cell Metab (2011) 4.00
Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer (2010) 3.48
Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med (1984) 3.41
Specialization of tumour vasculature. Nat Rev Cancer (2002) 3.30
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol (2007) 3.19
Co-evolution of tumor cells and their microenvironment. Trends Genet (2008) 3.08
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation (1991) 2.61
Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med (2006) 2.57
Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat Rev Cancer (2008) 2.12
Can cancer be reversed by engineering the tumor microenvironment? Semin Cancer Biol (2008) 2.07
Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer (1996) 1.84
Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem (2005) 1.82
Inflammation in end-stage renal disease--what have we learned in 10 years? Semin Dial (2010) 1.82
The endothelial cell. Br Med J (1966) 1.75
Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol (2008) 1.75
Integrins and angiogenesis: a sticky business. Exp Cell Res (2005) 1.69
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Res (2011) 1.69
Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci U S A (2008) 1.60
Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest (1992) 1.55
Stromal endothelial cells directly influence cancer progression. Sci Transl Med (2011) 1.46
Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc Natl Acad Sci U S A (2000) 1.25
Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. Circ Res (1993) 1.25
Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol (2009) 1.17
Molecular heterogeneity of tumor endothelium. Cell Tissue Res (2008) 1.13
Tissue engineered perivascular endothelial cell implants regulate vascular injury. Proc Natl Acad Sci U S A (1995) 1.12
Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation (1996) 1.10
Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention. Int J Cancer (2008) 1.07
Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium. Cancer Res (2010) 1.07
Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem (2007) 1.05
Endothelial regeneration: studies with human endothelial cells in culture. Ser Haematol (1973) 1.04
Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J Vasc Surg (2007) 1.04
Endothelial cell biology: role in the inflammatory response. Adv Clin Chem (2010) 1.03
Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate airway repair. Proc Natl Acad Sci U S A (2008) 0.96
Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth. J Cell Biochem (1993) 0.94
Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth. J Cell Physiol (2000) 0.91
Dysregulation of the endothelial cellular response to oxidative stress in cancer. Mol Carcinog (2006) 0.91
Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks. Curr Pharm Des (2007) 0.90
Tissue engineering of endothelial cells and the immune response. Transplant Proc (2006) 0.89
Thrombopoietic cells and the bone marrow vascular niche. Ann N Y Acad Sci (2007) 0.86
Endothelial cell delivery for cardiovascular therapy. Adv Drug Deliv Rev (2000) 0.86
Tumor blood vessels, a difficult hurdle for infiltrating leukocytes. Biochim Biophys Acta (2007) 0.82
Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med (2015) 5.36
Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol (2007) 4.62
Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation (2011) 3.16
Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem (2007) 3.06
Luminal flow patterns dictate arterial drug deposition in stent-based delivery. J Control Release (2008) 1.90
Tissue engineering therapy for cardiovascular disease. Circ Res (2003) 1.87
Prediction of the localization of high-risk coronary atherosclerotic plaques on the basis of low endothelial shear stress: an intravascular ultrasound and histopathology natural history study. Circulation (2008) 1.74
Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation (2003) 1.72
Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation (2012) 1.70
Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice. Circ Res (2008) 1.64
Stromal endothelial cells directly influence cancer progression. Sci Transl Med (2011) 1.46
In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Nat Mater (2011) 1.46
Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation (2002) 1.45
Ultrasound-guided percutaneous delivery of tissue-engineered endothelial cells to the adventitia of stented arteries controls the response to vascular injury in a porcine model. J Vasc Surg (2012) 1.42
Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci U S A (2004) 1.32
Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res (2005) 1.32
Aldehyde-amine chemistry enables modulated biosealants with tissue-specific adhesion. Adv Mater (2009) 1.31
Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. J Control Release (2007) 1.29
Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol (2005) 1.27
Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation (2005) 1.26
Natural history of experimental coronary atherosclerosis and vascular remodeling in relation to endothelial shear stress: a serial, in vivo intravascular ultrasound study. Circulation (2010) 1.19
Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression. Am J Physiol Heart Circ Physiol (2007) 1.18
Characterization of star adhesive sealants based on PEG/dextran hydrogels. Macromol Biosci (2009) 1.18
Luminal flow amplifies stent-based drug deposition in arterial bifurcations. PLoS One (2009) 1.17
Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res (2003) 1.12
Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway. Circ Res (2008) 1.11
Arterial ultrastructure influences transport of locally delivered drugs. Circ Res (2002) 1.11
Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs. Circulation (2011) 1.11
Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation (2002) 1.11
Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds? Circulation (2003) 1.06
Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem (2007) 1.05
Cardiology is flow. Circulation (2006) 1.04
Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J Vasc Surg (2007) 1.04
Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation (2003) 1.03
Impact of transport and drug properties on the local pharmacology of drug-eluting stents. Int J Cardiovasc Intervent (2003) 1.02
Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. J Clin Invest (2004) 1.02
Matrix embedding alters the immune response against endothelial cells in vitro and in vivo. Circulation (2005) 1.02
Lesion complexity determines arterial drug distribution after local drug delivery. J Control Release (2009) 1.00
Smooth muscle cells orchestrate the endothelial cell response to flow and injury. Circulation (2010) 1.00
The role of low endothelial shear stress in the conversion of atherosclerotic lesions from stable to unstable plaque. Curr Opin Cardiol (2009) 0.98
Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis. Int J Cancer (2013) 0.98
Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation (2005) 0.98
Viscoelastic adhesive mechanics of aldehyde-mediated soft tissue sealants. Biomaterials (2008) 0.97
Natural tissue microenvironmental conditions modulate adhesive material performance. Langmuir (2012) 0.97
Regulation of endothelial cell proliferation by primary monocytes. Arterioscler Thromb Vasc Biol (2007) 0.96
Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate airway repair. Proc Natl Acad Sci U S A (2008) 0.96
Thrombus causes fluctuations in arterial drug delivery from intravascular stents. J Control Release (2008) 0.95
Matrix adherence of endothelial cells attenuates immune reactivity: induction of hyporesponsiveness in allo- and xenogeneic models. FASEB J (2007) 0.94
Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle. Proc Natl Acad Sci U S A (2012) 0.94
Role of fluid dynamics and inflammation in intracranial aneurysm formation. Circulation (2014) 0.93
Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques. Atherosclerosis (2008) 0.93
Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation (2004) 0.93
Cells in fluidic environments are sensitive to flow frequency. J Cell Physiol (2005) 0.92
Endothelial immunogenicity--a matter of matrix microarchitecture. Thromb Haemost (2007) 0.91
Endothelial cell-matrix interactions determine maturation of dendritic cells. Eur J Immunol (2007) 0.90
Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord (2010) 0.90
Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury. Am J Physiol Heart Circ Physiol (2007) 0.90
Quasi-steady-state kinetics at enzyme and substrate concentrations in excess of the Michaelis-Menten constant. J Theor Biol (2006) 0.90
Cell-matrix contact prevents recognition and damage of endothelial cells in states of heightened immunity. Circulation (2006) 0.90
Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med (2003) 0.90
Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine. Atherosclerosis (2010) 0.89
The effect of three-dimensional matrix-embedding of endothelial cells on the humoral and cellular immune response. Semin Immunol (2008) 0.89
Analysis of compartmental models of ligand-induced endocytosis. J Theor Biol (2004) 0.89
Endosomal receptor kinetics determine the stability of intracellular growth factor signalling complexes. Biochem J (2007) 0.88
Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation (2004) 0.87
Anti-atherosclerotic therapy based on botanicals. Recent Pat Cardiovasc Drug Discov (2013) 0.87
Low background, pulsatile, in vitro flow circuit for modeling coronary implant thrombosis. J Biomech Eng (2002) 0.87
A structural model that explains the effects of hyperglycemia on collagenolysis. Biophys J (2003) 0.87
Augmentation of postswelling surgical sealant potential of adhesive hydrogels. J Biomed Mater Res A (2010) 0.86
Phosphorylation-induced conformational changes in a mitogen-activated protein kinase substrate. Implications for tyrosine hydroxylase activation. J Biol Chem (2002) 0.86
Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB. Blood (2005) 0.86
Effect of pre-adsorbed proteins on attachment, proliferation, and function of endothelial cells. J Cell Physiol (2002) 0.86
Acute rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant (2014) 0.86
Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance. J Am Coll Cardiol (2012) 0.86
Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy. Circulation (2013) 0.85
The effect of substrate modulus on the growth and function of matrix-embedded endothelial cells. Biomaterials (2012) 0.85
Pushing drug-eluting stents into uncharted territory: simpler than you think--more complex than you imagine. Circulation (2006) 0.85
Environmental influences on endovascular stent platelet reactivity: an in vitro comparison of stainless steel and gold surfaces. J Biomed Mater Res A (2004) 0.85
Local and systemic drug competition in drug-eluting stent tissue deposition properties. J Control Release (2005) 0.85
Impact of flow pulsatility on arterial drug distribution in stent-based therapy. J Control Release (2013) 0.85
Tubular bridges for bronchial epithelial cell migration and communication. PLoS One (2010) 0.85
Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress. Arterioscler Thromb Vasc Biol (2013) 0.85
Collagen fragments modulate innate immunity. Exp Biol Med (Maywood) (2007) 0.84
The role of scaffold microarchitecture in engineering endothelial cell immunomodulation. Biomaterials (2012) 0.84
Stent elution rate determines drug deposition and receptor-mediated effects. J Control Release (2012) 0.84
C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur J Haematol (2007) 0.84
Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2. Arterioscler Thromb Vasc Biol (2011) 0.84
Cellular bridges: Routes for intercellular communication and cell migration. Commun Integr Biol (2010) 0.84
Engineered arterial models to correlate blood flow to tissue biological response. Ann N Y Acad Sci (2012) 0.83
Delivery site of perivascular endothelial cell matrices determines control of stenosis in a porcine femoral stent model. J Vasc Interv Radiol (2009) 0.83
Neointimal formation is reduced after arterial injury in human crp transgenic mice. Atherosclerosis (2008) 0.83
Assessment of material by-product fate from bioresorbable vascular scaffolds. Ann Biomed Eng (2011) 0.83
On the validity of the quasi-steady state approximation of bimolecular reactions in solution. J Theor Biol (2005) 0.83
Optimal control of blood glucose: the diabetic patient or the machine? Sci Transl Med (2010) 0.83
Monocyte activation state regulates monocyte-induced endothelial proliferation through Met signaling. Blood (2010) 0.83
Risk stratification of individual coronary lesions using local endothelial shear stress: a new paradigm for managing coronary artery disease. Curr Opin Cardiol (2007) 0.82
NF-kappaB activity in endothelial cells is modulated by cell substratum interactions and influences chemokine-mediated adhesion of natural killer cells. Cell Transplant (2009) 0.82
Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors. Circ Heart Fail (2009) 0.81
High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery. J Control Release (2013) 0.81
Intramuscular drug transport under mechanical loading: resonance between tissue function and uptake. J Control Release (2009) 0.81